15 Results for "

NR2B subunit

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "NR2B subunit" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-13993
CAS No.: 169274-78-6
Purity:  99.55%
Target:  

iGluR

Research Areas:  

Neurological Disease

Ro 25-6981 is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
10
10 Publications Verification
Cat. No.: HY-13993A
CAS No.: 1312991-76-6
Purity:  99.25%
Target:  

iGluR

Research Areas:  

Neurological Disease

Ro 25-6981 Maleate is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 Maleat shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 Maleate has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-136299
CAS No.: 103926-64-3
Purity:  98.00%
Synonyms: FUT-187 free base
Target:  

iGluR

Research Areas:  

Neurological Disease

Sepimostat (FUT-187 free base) exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat inhibits the Ifenprodil binding with a Ki value of 27.7?μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-136299B
Synonyms: FUT-187 trifluoroacetate
Target:  

iGluR

Research Areas:  

Neurological Disease

Sepimostat (FUT-187) trifluoroacetate exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat trifluoroacetate inhibits the Ifenprodil binding with a Ki value of 27.7 μM .
loading...
    loading...
Cat. No.: HY-145585
CAS No.: 1892581-29-1
Synonyms: MIJ-821
Target:  

iGluR

Research Areas:  

Neurological Disease

Onfasprodil (MIJ-821) is a selective intravenous NMDA receptor NR2B subunit negative allosteric modulator (NAM). Onfasprodil inhibits the activity of NR2B-NMDA receptors. Onfasprodil has a rapid antidepressant effect. Onfasprodil can be used for the research of treatment-resistant depression (TRD) .
loading...
    loading...
Cat. No.: HY-136299A
CAS No.: 103926-82-5
Synonyms: FUT-187
Target:  

iGluR

Research Areas:  

Neurological Disease

Sepimostat dimethanesulfonate (FUT-187) exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat dimethanesulfonate inhibits the Ifenprodil binding with a Ki value of 27.7 µM .
loading...
    loading...
Cat. No.: HY-137049
CAS No.: 193359-26-1
Synonyms: PD 174494
Target:  

iGluR

Research Areas:  

Others

Co-101244 (PD 174494) is an NMDA receptor blocker that specifically targets the NR2B subunit.
loading...
    loading...
Cat. No.: HY-136659
CAS No.: 194089-07-1
Target:  

iGluR

Research Areas:  

Others

Ro 04-5595 is a selective antagonist with specific activity against the NR2B subunit of the NMDA receptor. Ro 04-5595 exhibits favorable pharmacokinetic properties in in vitro and in vivo studies, with rapid uptake and clearance. Ro 04-5595 exhibits strong binding in NR2B receptor-enriched regions and low binding in the cerebellum. Ro 04-5595 is able to effectively inhibit specific binding, showing high affinity for the NR2B receptor and a clear ranking of binding affinity with a variety of other compounds .
loading...
    loading...
Cat. No.: HY-136299R
CAS No.: 103926-64-3
Synonyms: FUT-187 free base (Standard)
Research Areas:  

Neurological Disease

Sepimostat (Standard) is the analytical standard of Sepimostat. This product is intended for research and analytical applications. Sepimostat (FUT-187 free base) exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat inhibits the Ifenprodil binding with a Ki value of 27.7 μM .
loading...
    loading...
Cat. No.: HY-121100
CAS No.: 305339-41-7
Purity:  99.81%
Target:  

iGluR

Research Areas:  

Neurological Disease

BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit, with a Ki of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation .
loading...
    loading...
Cat. No.: HY-13993B
CAS No.: 919289-58-0
Target:  

iGluR

Research Areas:  

Neurological Disease

Ro 25-6981 hydrochloride is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist. Ro 25-6981 hydrochloride shows anticonvulsant and anti-parkinsonian activity. Ro 25-6981 hydrochloride has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-107708
CAS No.: 1312991-83-5
threo Ifenprodil hemitartrate is a σ receptor agonist, with Kis of 59.1 and 2 nM for σ1 and σ2 receptors, respectively. threo Ifenprodil hemitartrate is also a NR2B subunit-selective NMDA receptor antagonist (IC50=0.22 μM). threo Ifenprodil hemitartrate is a hERG potassium channel inhibitor, with an IC 50 of 88 nM, showing antiarrhythmic activity .
loading...
    loading...
Cat. No.: HY-184055
CAS No.: 2643356-08-3
Target:  

iGluR

Research Areas:  

Neurological Disease

NMDA receptor antagonist-12 (Example 17) is an antagonist of NMDA receptors containing the NR2B subunit. NMDA receptor antagonist-12 exerts antagonistic effects on NMDA receptors containing the NR2B subunit and blocks the intracellular Ca 2+ influx mediated by these receptors. NMDA receptor antagonist-12 can be used in research related to diseases such as depression, bipolar disorder, migraine, and pain .
loading...
    loading...
Cat. No.: HY-182628
CAS No.: 951248-25-2
Target:  

iGluR

CJ-036878 is a NMDAR NR2B subunit antagonist. CJ-036878 is applicable to research related to persistent inflammatory pain and neuropathic pain .
loading...
    loading...
Cat. No.: HY-D3369
CAS No.: 3114128-44-5
Target:  

Fluorescent Dye iGluR

Research Areas:  

Neurological Disease

Tz‑IFDL is a chemiluminescent probe for in vivo imaging of N‑methyl‑D‑aspartate receptors (NMDAR), which specifically binds to the NR2B subunit of NMDAR. Tz‑IFDL undergoes a bioorthogonal reaction with probe CL‑NC (HY-D3370), triggering molecular fragment release and chemiluminescence. The CL‑NC/Tz‑IFDL system composed of Tz‑IFDL exhibits a chemiluminescence emission wavelength of 710 nm. When combined with CL‑NC, Tz‑IFDL can be used for deep tissue imaging to distinguish NMDAR expression levels between Alzheimer's disease model mice and normal mice .
loading...
    loading...
  • 1